Recova Pharma Expo Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
- Paid Up Capital ₹ 1.10 M
- Company Age 18 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 12.80 Cr
- Satisfied Charges ₹ 9.90 Cr
- Revenue Growth 5.18%
- Profit Growth 794.45%
- Ebitda -1884.43%
- Net Worth 5.30%
- Total Assets 6.43%
About Recova Pharma Expo
Recova Pharma Expo Private Limited (RPEPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 20 March 2006 and has a history of 18 years and 11 months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 1.10 M.
The company currently has active open charges totaling ₹12.80 Cr. The company has closed loans amounting to ₹9.90 Cr, as per Ministry of Corporate Affairs (MCA) records.
Naresh Goel, Ramesh Goel, and Gyanesh Jeswal serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U99999DL2006PTC147727
- Company No.
147727
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Mar 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Recova Pharma Expo Private Limited offer?
Recova Pharma Expo Private Limited offers a wide range of products and services, including Pharmaceutical Medicine, Pharmaceutical Drug, Antiseptic Gel, Lotion & Cream, Povidone Iodine Ointment, Antiparasitic Drug, Albendazole Tablets, Anti Allergic Drug, Allergy Relief Tablets.
Who are the key members and board of directors at Recova Pharma Expo?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naresh Goel  | Director | 20-Mar-2006 | Current |
| Ramesh Goel | Director | 27-May-2014 | Current |
| Gyanesh Jeswal | Director | 23-Jul-2007 | Current |
Financial Performance of Recova Pharma Expo.
Recova Pharma Expo Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 5.18% increase. The company also saw a substantial improvement in profitability, with a 794.45% increase in profit. The company's net worth moved up by a moderate rise of 5.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Recova Pharma Expo?
In 2023, Recova Pharma Expo had a promoter holding of 25.00% and a public holding of 75.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Austro Labs LimitedNaresh Goel is a mutual person
Sun Medilab Private LimitedNaresh Goel and Ramesh Goel are mutual person
- Warner India Lifesciences Limited
Naresh Goel and Gyanesh Jeswal are mutual person
- Sentosa Geigy (India) Labs Limited
Naresh Goel and Ramesh Goel are mutual person
- Cogni Labs Limited
Naresh Goel is a mutual person
- Shrish Enterprises Private Limited
Naresh Goel and Ramesh Goel are mutual person
Charges (Loans)
₹128.00 M
₹99.00 M
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 12.80 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Oct 2024 | Axis Bank Limited | ₹10.00 Cr | Open |
| 18 Apr 2022 | Axis Bank Limited | ₹8.00 M | Open |
| 23 Mar 2021 | Axis Bank Limited | ₹2.00 Cr | Open |
| 01 Feb 2014 | Axis Bank Limited | ₹9.90 Cr | Satisfied |
How Many Employees Work at Recova Pharma Expo?
Recova Pharma Expo has a workforce of 2 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Recova Pharma Expo, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Recova Pharma Expo's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
